Article
A pilot study of corticosteroid priming for lymphoblastoid interferon alfa in patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) - 1 May 1996
Chayama K, Tsubota A, Kobayashi M, Hashimoto M, Miyano Y, Koike H, Kobayashi M, Koida I, Arase Y, Saitoh S, Murashima N, Ikeda K, Kumada H
Abstract excerpt
Interferon treatment reduces the serum level of hepatitis C virus (HCV) and improves inflammatory activity, but relapse is frequently observed. In an attempt to develop a new therapeutic strategy that may reduce relapse and cure the disease, we evaluated the effect of corticosteroid priming on lymphoblastoid interferon alfa in an open randomized clinical trial. The level of HCV RNA increased significantly during...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.